Showing results (11-20 of 84) with videos related to
Sort By:
Pageof 9
The Journal of Antimicrobial Chemotherapy|March 24, 2022
Rapid determination of ceftazidime/avibactam susceptibility of carbapenemase-producing Enterobacterales directly from blood cultures: a comparative evaluation of EUCAST disc diffusion RAST and direct Etest® RASTGabriele Bianco, Matteo Boattini, Sara Comini, et al.Microbial Drug Resistance (Larchmont, N.Y.)|November 13, 2020
Direct Ethylenediaminetetraaceticacid-Modified β-Lactam Inactivation Method: An Improved Method to Identify Serine-Carbapenemase-, Metallo-β-Lactamase-, and Extended-Spectrum-β-Lactamase-Producing Enterobacterales Directly from Positive Blood CultureGabriele Bianco, Matteo Boattini, Marco Iannaccone, et al.Journal of Clinical Microbiology|November 8, 2019
Direct β-Lactam Inactivation Method: a New Low-Cost Assay for Rapid Detection of Carbapenemase- or Extended-Spectrum-β-Lactamase-Producing <i>Enterobacterales</i> Directly from Positive Blood Culture BottlesGabriele Bianco, Matteo Boattini, Marco Iannaccone, et al.International Journal of Antimicrobial Agents|April 16, 2026
In vivo emergence of cross-resistance to ceftazidime/avibactam and cefiderocol through selection of KPC variants in Klebsiella pneumoniae clinical isolatesGabriele Bianco, Jacqueline Findlay, Sara Comini, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 19, 2024
Performance evaluation of Bruker UMIC<sup>®</sup> microdilution panel and disc diffusion to determine cefiderocol susceptibility in Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Achromobacter xylosoxidans and Burkolderia speciesGabriele Bianco, Matteo Boattini, Sara Comini, et al.Viruses|April 27, 2024
From Forgotten Pathogen to Target for New Vaccines: What Clinicians Need to Know about Respiratory Syncytial Virus Infection in Older AdultsMatteo Boattini, André Almeida, Sara Comini, et al.Antibiotics (Basel, Switzerland)|March 29, 2023
Disc Diffusion and ComASP<sup>®</sup> Cefiderocol Microdilution Panel to Overcome the Challenge of Cefiderocol Susceptibility Testing in Clinical Laboratory RoutineGabriele Bianco, Matteo Boattini, Sara Comini, et al.Antimicrobial Agents and Chemotherapy|April 13, 2022
Increased <i>bla</i><sub>KPC</sub> Copy Number and OmpK35 and OmpK36 Porins Disruption Mediated Resistance to Imipenem/Relebactam and Meropenem/Vaborbactam in a KPC-Producing Klebsiella pneumoniae Clinical IsolatePaolo Gaibani, Gabriele Bianco, Stefano Amadesi, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 31, 2021
In vitro activity of cefiderocol against ceftazidime-avibactam susceptible and resistant KPC-producing Enterobacterales: cross-resistance and synergistic effectsGabriele Bianco, Matteo Boattini, Sara Comini, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 21, 2022
Occurrence of multi-carbapenemases producers among carbapenemase-producing Enterobacterales and in vitro activity of combinations including cefiderocol, ceftazidime-avibactam, meropenem-vaborbactam, and aztreonam in the COVID-19 eraGabriele Bianco, Matteo Boattini, Sara Comini, et al.Pageof 9